A comprehensive guide to ICD-10-CM code Q53

In the vast, intricate language of modern medicine, the ICD-10-CM code Q53 stands as a deceptively simple entry: “Undescended testicle.” To the medical coder, it is a precise alphanumeric string used for billing and data tracking. To the clinician, it is a diagnosis that triggers a specific pathway of evaluation and management. But to the infant boy and his family, it represents a journey interrupted—a tiny organ that, for reasons often unknown, failed to complete its crucial migration from the depths of the abdomen to its designated sanctuary in the scrotum. This condition, known medically as cryptorchidism (from the Greek kryptos, meaning “hidden,” and orchis, meaning “testicle”), is the most common endocrine disorder affecting newborn males, yet its implications ripple far beyond infancy.

This article delves deep into the world of Q53, moving far beyond the confines of a medical classification code. We will embark on a detailed exploration of the fascinating embryology that dictates normal testicular descent and the myriad factors that can disrupt this delicate process. We will unpack the clinical spectrum of cryptorchidism, from the easily palpable inguinal testis to the truly absent organ. The significant long-term consequences—impaired fertility and a heightened risk of testicular cancer—will be examined in detail, underscoring why timely intervention is not merely a procedural formality but a critical component of lifelong male health.

Furthermore, we will dissect the diagnostic and therapeutic arsenal available to pediatric urologists and endocrinologists, from hormonal therapies to sophisticated surgical techniques like laparoscopic orchidopexy. Woven throughout this clinical narrative will be the indispensable thread of medical coding, illustrating how the accurate application of Q53 and its subcategories is vital not only for healthcare reimbursement but also for epidemiological research, public health planning, and the continuous improvement of patient care standards. This is the comprehensive story of Q53—a story of development, deviation, and the dedicated medical response to guide a wayward organ home.

2. Deciphering Q53: A Look at the ICD-10-CM Framework

Before delving into the clinical aspects, it is essential to understand the coding system that gives this condition its formal identity. The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) is the standard system used in the United States to classify and code all diagnoses, symptoms, and procedures.

The Structure of ICD-10-CM

ICD-10-CM codes are alphanumeric and can range from three to seven characters in length. The structure is hierarchical:

• Chapter: The first character is a letter, representing a broad chapter (e.g., Q00-Q99 for Congenital Malformations, Deformations and Chromosomal Abnormalities).

• Category: The first three characters (e.g., Q53) define the general category of the disease or condition.

• Subcategory and Extension: Characters four through seven provide increasing specificity regarding etiology, anatomical site, severity, and other clinical details.

The Specifics of Code Q53

Code Q53 falls under Chapter 17: Congenital Malformations, Deformations and Chromosomal Abnormalities, and more specifically, within the block Q50-Q56, “Congenital malformations of genital organs.” The code Q53 requires a fourth digit to specify the nature and location of the undescended testicle, making it invalid if used alone.

Here are the specific codes under the Q53 family:

• Q53.0 – Ectopic testis: This code is used when the testis has descended but has been misdirected to an abnormal location outside the normal path of descent. Common ectopic sites include the perineum, femoral canal (thigh), superficial inguinal pouch (above the inguinal canal), or the penile base.

  • Coding Note: This is distinct from a testis that is simply arrested along the normal path.

• Q53.1 – Undescended testicle, unilateral: This code is used when one testis has failed to descend into the scrotum. The contralateral (other) testis is normal in position.

  • Coding Note: The side (left or right) is not specified in the code itself but is a critical component of the clinical documentation that supports the code.

• Q53.2 – Undescended testicle, bilateral: This code is used when both testes have failed to descend. This is a less common presentation than the unilateral form but often carries greater implications for future fertility.

• Q53.9 – Undescended testicle, unspecified: This code is a “catch-all” used when the medical documentation states “undescended testicle” or “cryptorchidism” but does not specify whether it is unilateral, bilateral, or ectopic. Its use is generally discouraged as it lacks specificity, which can impact data quality.

Exclusions and Related Codes

It is crucial for coders to understand what Q53 does not include.

• Excludes1: Retractile testis (N44.02). This is a critical distinction. A retractile testis is a normally descended testis that retracts vigorously into the inguinal canal due to an overactive cremasteric reflex. It is not a true congenital malformation and does not typically require surgical intervention. It is coded elsewhere, under diseases of the genitourinary system.

 ICD-10-CM Codes for Cryptorchidism and Related Conditions

3. The Journey of the Testis: Normal Embryological Descent

To understand what goes wrong in cryptorchidism, one must first appreciate the remarkable and complex journey of the testis during fetal development. This process is a masterpiece of embryological timing, hormonal signaling, and anatomical transformation.

The Gonadal Ridge and Primordial Germ Cells

Around the fifth week of gestation, the gonads begin to form as a pair of longitudinal ridges (the gonadal ridges) on the posterior abdominal wall. These indifferent gonads are initially identical in male and female embryos. The critical cells that will become the sperm—the primordial germ cells—migrate from the yolk sac into these ridges.

The Gubernaculum: The Guide Rope

A key structure in testicular descent is the gubernaculum. This is a cord-like ligament that extends from the lower pole of the testis down to the developing scrotum. In males, the gubernaculum undergoes a crucial phase known as the “swelling reaction,” where it thickens and shortens, creating a path through the abdominal wall and into the scrotum. Think of it as an anchor line that shortens, pulling the testis down behind it.

Hormonal Orchestration: The Role of Testosterone and MIS

The descent is not a passive process; it is actively driven by hormones.

• Testosterone: Produced by the fetal Leydig cells of the testis, testosterone is the primary driver. It stimulates the development of the Wolffian ducts into the male internal genitalia (epididymis, vas deferens) and is essential for the swelling and contraction of the gubernaculum.

• Müllerian Inhibiting Substance (MIS) or Anti-Müllerian Hormone (AMH): Also produced by the fetal testis (Sertoli cells), MIS causes the regression of the Müllerian ducts, which would otherwise develop into female internal structures (uterus, fallopian tubes). Its role in descent is also critical, working in concert with testosterone.

• Insulin-like factor 3 (INSL3): This hormone, produced by Leydig cells, has been identified as a major regulator of the gubernacular swelling reaction. Mutations in the INSL3 gene or its receptor (RXFP2) are associated with cryptorchidism.

The Process of Migration

Testicular descent occurs in two main phases:

1. The Transabdominal Phase (8-15 weeks gestation): The testis moves from the posterior abdominal wall to the future internal inguinal ring. This phase is largely controlled by INSL3.

2. The Inguinoscrotal Phase (25-35 weeks gestation): The testis moves from the internal ring, through the inguinal canal, and into the scrotum. This phase is primarily androgen (testosterone)-dependent.

Most testes have descended into the scrotum by the time of a full-term birth (40 weeks). Any testis not present in the scrotum at birth is considered cryptorchid until proven otherwise.

4. When the Journey Stops: Defining Cryptorchidism

Cryptorchidism is defined as the failure of one or both testes to descend into the scrotum by the expected time of birth. It is a condition that exists on a spectrum, with varying locations and implications.

Epidemiology and Prevalence

Cryptorchidism is the most common congenital anomaly of the male genitalia.

• Preterm Infants: The prevalence is significantly higher in preterm infants, affecting up to 30% of boys born before 37 weeks. This is simply because the descent process is often incomplete at the time of early birth.

• Full-Term Infants: Approximately 3-5% of full-term male newborns are born with at least one undescended testis.

• Spontaneous Descent: A significant number of these testes will descend spontaneously within the first three to six months of life, thanks to a postnatal surge of gonadotropins. By one year of age, the prevalence drops to about 1%.

• This 1% is the persistent cryptorchidism that requires medical intervention.

Risk Factors: Genetic, Maternal, and Environmental

The etiology of cryptorchidism is multifactorial, involving a complex interplay of genetics, maternal and fetal endocrine environment, and potential environmental disruptors.

• Genetic Factors: There is a clear familial tendency. A boy with a cryptorchidism has a higher chance of having a brother or father who was also affected. It is also associated with several genetic syndromes, such as:

  • Prader-Willi Syndrome

  • Noonan Syndrome

  • Kallmann Syndrome

  • Abdominal Wall Defects (e.g., Prune Belly Syndrome)

• Maternal and Fetal Factors:

  • Low Birth Weight / Prematurity: The single strongest risk factor.

  • Maternal Diabetes: Increases the risk.

  • Maternal Obesity / High BMI.

  • Maternal Smoking during pregnancy.

  • Alcohol Use during pregnancy.

• Endocrine Disruptors: This is an area of active research. The hypothesis is that exposure to environmental chemicals that mimic or block estrogen (e.g., phthalates, bisphenol A/BPA, pesticides) can interfere with the delicate hormonal balance required for normal testicular descent.

5. Classifying the Undescended Testicle: A Clinical Spectrum

Not all undescended testes are the same. Accurate classification is essential for determining prognosis and guiding management.

Palpable vs. Non-Palpable Testes

The first and most critical distinction a clinician makes during physical examination is whether the testis can be felt (palpated).

• Palpable (80% of cases): The testis can be felt somewhere along the normal path of descent, most commonly in the inguinal canal or just outside the external inguinal ring (the “superficial inguinal pouch”). These are often amenable to a standard inguinal orchidopexy.

• Non-Palpable (20% of cases): The testis cannot be felt. This scenario presents a diagnostic challenge. The possibilities are:

  1. Intra-abdominal: The testis is located inside the abdomen, often near the internal inguinal ring.

  2. Vanished/Absent (Testicular Regression Syndrome): The testicular tissue has atrophied due to a prenatal vascular event (like torsion).

  3. Very small or atrophic: The testis is present but so small it cannot be palpated.

True Cryptorchidism

This refers to a testis that is arrested along its normal path of descent. It can be:

• Abdominal: High in the abdomen.

• Canalicular: Within the inguinal canal.

• Emergent (or Pre-scrotal): Just at or outside the external inguinal ring.

Retractile Testis: A Common Mimic

This is the most important condition to differentiate from true cryptorchidism. A retractile testis has fully descended but is pulled back into the groin by a hyperactive cremaster muscle reflex. It can be manually manipulated into the scrotum without tension and will remain there, at least temporarily. It does not carry the same risks of infertility or malignancy and does not require surgery. It is coded as N44.02, not Q53.

Ectopic Testis

As coded by Q53.0, this is a testis that has descended completely but has been misdirected to an abnormal location. The gubernaculum has attached to the wrong place. Common sites include:

• Superficial Inguinal Pouch (the most common ectopic site, located anterior to the external oblique aponeurosis).

• Perineal (between the anus and the scrotum).

• Femoral (in the upper thigh).

• Penile (at the base of the penis).

• Crossed Ectopia (where both testes descend into the same hemiscrotum).

Ascending Testis (Acquired Undescended Testis)

This is a phenomenon where a testis that was previously documented in the scrotum appears to “ascend” out of it over time. It is believed to be due to the failure of the spermatic cord to elongate at the same rate as body growth, effectively pulling the testis back up. This is still considered a form of cryptorchidism and is coded with the Q53 series.

Vanished Testis (Testicular Regression Syndrome)

In this condition, a testis was present initially but was lost in utero, likely due to torsion or vascular accident. The remnant structures (often a small nubbin of tissue containing hemosiderin deposits and calcifications) may be found. This is coded as Q55.0 (Absence and aplasia of testis).

6. The Clinical Consequences of Maldescent: Why Treatment Matters

Leaving an undescended testis untreated is not an option. The scrotum provides an environment that is 2-3°C cooler than the core body temperature, which is essential for normal testicular function. An ectopic testis is exposed to higher temperatures, leading to a cascade of detrimental effects.

Impaired Fertility and Germ Cell Development

This is the most common complication. The process of spermatogenesis (sperm production) is exquisitely temperature-sensitive.

• Germ Cell Apoptosis: Even by one year of age, a cryptorchid testis shows a significant reduction in the number of germ cells (the future sperm-producing cells). There is evidence of increased apoptosis (programmed cell death).

• Histological Changes: Biopsies of undescended testes reveal abnormal development of the seminiferous tubules.

• Impact on the Contralateral Testis: There is some evidence that a unilateral cryptorchid testis can have a negative effect on the normally descended testis, possibly via an autoimmune mechanism.

• Fertility Rates: Men with a history of bilateral cryptorchidism have significantly higher rates of infertility. Even with timely surgery, fertility potential may be reduced. For unilateral cryptorchidism, fertility rates are nearly normal if orchidopexy is performed early, but they can be impaired if treatment is delayed.

Increased Risk of Testicular Malignancy

This is the most serious long-term risk.

• Relative Risk: A man with a history of cryptorchidism has a 2.5 to 8 times higher relative risk of developing testicular cancer compared to the general population.

• Lifetime Risk: The absolute lifetime risk is estimated to be about 1 in 1,000 to 1 in 2,500 for men with a history of cryptorchidism, compared to about 1 in 20,000 for the general male population.

• Site of the Testis: The risk is higher for an intra-abdominal testis than for an inguinal one.

• Does Orchidopexy Reduce the Risk? This is a critical point. Orchidopexy does not eliminate the cancer risk. The fundamental cellular defect that predisposes to cancer is likely present from the beginning. However, orchidopexy allows for regular testicular self-examination and makes it possible to detect a tumor at an early, treatable stage. An intra-abdominal tumor would be impossible to palpate and would present at a very advanced stage.

Testicular Torsion: A Surgical Emergency

An undescended testis, particularly one in the inguinal canal, is at a higher risk for torsion (twisting of the spermatic cord, cutting off blood supply). This is a surgical emergency, and the “bell-clapper” deformity, a common anatomical variant predisposing to torsion, is more frequent in cryptorchid testes.

Inguinal Hernia: A Common Associated Finding

Over 90% of boys with an undescended testis have a patent processus vaginalis, which is the embryonic connection between the abdomen and the scrotum. If this remains open, it can allow abdominal contents to herniate into the inguinal canal, creating an inguinal hernia. Repair of the hernia is routinely performed at the same time as the orchidopexy surgery.

Psychological and Body Image Considerations

Having an “empty” or asymmetrical scrotum can be a source of anxiety and embarrassment for boys as they grow older, particularly during adolescence. Successful orchidopexy and, if necessary, the placement of a testicular prosthesis, can have significant positive psychological benefits.

7. The Diagnostic Pathway: From History to Imaging

The diagnosis of cryptorchidism is primarily clinical, relying on a careful history and a skilled physical examination.

The Importance of a Detailed History

The clinician will ask about:

• Gestational age and birth weight (prematurity is a key risk factor).

• Whether the testis was ever noted to be in the scrotum.

• Family history of cryptorchidism or other genital anomalies.

• Maternal history during pregnancy (e.g., smoking, diabetes).

The Physical Examination: Technique and Timing

The examination is the cornerstone of diagnosis.

• Environment: The room should be warm, and the child should be as relaxed as possible, ideally lying supine in a frog-leg position or sitting cross-legged.

• Technique: The examiner uses a “milking” maneuver, applying gentle, steady pressure from the lower abdomen down towards the scrotum with one hand, while the other hand is ready to palpate the testis as it is guided into the scrotum.

• Timing: The best time to examine is in the first few months of life. However, the examination can be challenging due to the strong cremasteric reflex and infant distress. Re-examination at subsequent well-child visits is crucial.

The Role of Ultrasound and Other Imaging Modalities

• Ultrasound: This is the most commonly used imaging study. It is excellent for locating a testis in the inguinal canal. However, its utility is limited for detecting an intra-abdominal testis, as bowel gas can obscure the view. A negative ultrasound does not rule out the presence of a testis.

• MRI/CT: These are rarely used. They involve radiation (CT) or often require sedation in a child (MRI), and their accuracy is not superior to diagnostic laparoscopy.

Diagnostic Laparoscopy: The Gold Standard for Non-Palpable Testes

For a non-palpable testis, diagnostic laparoscopy is the definitive procedure. A small camera is inserted into the abdomen, allowing direct visualization. The findings can be:

1. Blind-ending spermatic vessels inside the abdomen: Confirms a vanished testis (testicular regression). No further exploration is needed.

2. Spermatic vessels and vas deferens entering the inguinal canal: The testis is likely canalicular or atrophic. An inguinal exploration is performed.

3. An intra-abdominal testis: Visualized clearly within the abdomen. The surgeon can then proceed with a laparoscopic orchidopexy.

8. Therapeutic Interventions: Guiding the Testis Home

The goal of treatment is to position the testis in a stable, dependent position within the scrotum to optimize its function, allow for monitoring, and reduce the risk of complications.

Watchful Waiting: The First Few Months of Life

Given the high rate of spontaneous descent in the first 3-6 months, the initial management for a full-term infant is observation. If the testis has not descended by 6 months of age, spontaneous descent is highly unlikely, and intervention is recommended.

Hormonal Therapy: The Role of hCG and GnRH

This therapy aims to stimulate the endogenous production of testosterone, which may promote testicular descent.

• hCG (Human Chorionic Gonadotropin): Mimics the action of Luteinizing Hormone (LH), stimulating Leydig cells to produce testosterone.

• GnRH (Gonadotropin-Releasing Hormone) analogues: Stimulate the pituitary to release its own gonadotropins (LH and FSH).

• Success Rates: Hormonal therapy has variable success rates (reported from <20% to over 50%), and it is generally more effective for low, palpable testes. Its use is more common in Europe than in North America, where surgical intervention is often preferred as the primary treatment due to its higher and more predictable success rate.

Surgical Orchidopexy: The Definitive Treatment

Orchidopexy (or orchiopexy) is the surgical fixation of the testis in the scrotum. It is the gold standard treatment. The optimal timing, as recommended by the American Urological Association (AUA) and other professional bodies, is between 6 and 12 months of age, and certainly before 18 months.

The Inguinal Orchidopexy

This is the standard procedure for palpable testes.

1. Incision: A small incision is made in the groin, over the inguinal canal.

2. Mobilization: The testis is identified and carefully freed from all surrounding tissues. The hernia sac (patent processus vaginalis) is identified, separated from the vas deferens and vessels, and ligated (closed off).

3. Division of Cremaster Muscle: This helps prevent future retraction.

4. Creation of a Dartos Pouch: A small pocket is created in the scrotum between the skin and the underlying tissue (dartos fascia).

5. Fixation: The testis is brought down into the scrotum without tension and secured within the dartos pouch. This technique prevents retraction.

The Laparoscopic Approach

This is the preferred method for non-palpable testes confirmed or suspected to be intra-abdominal.

1. Port Placement: Three small (3-5mm) incisions are made in the abdomen.

2. Exploration: The abdomen is insufflated with gas, and the laparoscope is used to locate the testis.

3. Mobilization: The testis and its blood supply are meticulously freed.

4. Creation of a Path: A new path is created for the testis into the scrotum.

5. Fixation: The testis is pulled into the scrotum and fixed, as in the open procedure.

The Single-Incision Laparoscopic Surgery (SILS)

A more advanced, cosmetically superior technique where all instruments and the camera are inserted through a single small incision, often through the umbilicus.

The Fowler-Stephens Procedure

This is a specialized technique used for a high intra-abdominal testis with a short spermatic cord that cannot reach the scrotum without tension. It is performed in one or two stages.

• Principle: The main blood supply from the spermatic vessels is deliberately divided. The testis then survives on its secondary blood supply from the vas deferens (the artery of the vas) and the cremasteric vessels.

• Staged Approach: Often, the vessels are clipped in a first surgery, allowing the collateral blood supply to strengthen over 6 months. In a second surgery, the testis is mobilized on its new blood supply and brought down.

Post-Operative Care and Complications

• Care: Most orchidopexies are performed as outpatient procedures. Recovery is quick, with advice to avoid strenuous activity for a few weeks.

• Complications: These are rare but can include bleeding, infection, injury to the vas deferens or blood vessels, and testicular atrophy (loss of the testis due to compromised blood supply). The overall success rate for a standard orchidopexy is over 95%.

9. Long-Term Outcomes and Follow-Up Care

Management does not end with a successful surgery. Boys with a history of cryptorchidism require lifelong awareness and follow-up.

Fertility Potential After Orchidopexy

Early orchidopexy (before 12-18 months) offers the best chance for preserving fertility, particularly in unilateral cases. Men with a history of treated unilateral cryptorchidism have near-normal paternity rates. For bilateral cases, the chances of infertility are higher, but many men can still father children, sometimes with the aid of assisted reproductive technologies.

Lifelong Cancer Surveillance

This is non-negotiable. The risk of testicular cancer, while reduced by scrotal placement, persists. The most common type is seminoma, and it typically presents in the 3rd and 4th decades of life.

• Testicular Self-Examination (TSE): Men should be taught to perform monthly TSE to become familiar with the feel of their testes and to report any new lumps, hardness, or changes promptly.

• Clinical Follow-up: Regular check-ups with a primary care physician or urologist are recommended, especially during young adulthood.

Management of the Absent Testis: Prosthesis and Counseling

In cases of a vanished testis (or if a testis is removed due to atrophy or tumor), a testicular prosthesis can be placed. This is a saline-filled silicone implant that recreates the scrotal contour. The decision is often made in adolescence. Counseling is important to address body image concerns.

10. The Critical Role of Medical Coding: Q53 in Practice

The accurate application of ICD-10-CM code Q53 is far more than an administrative task; it is a fundamental component of modern healthcare delivery.

Why Accurate Coding Matters

• Reimbursement: Correct codes are essential for hospitals and physicians to receive appropriate payment from insurance companies for the services rendered (e.g., office visits, surgery).

• Clinical Decision Support: Coded data populates the patient’s electronic health record (EHR), providing a clear history for future clinicians.

• Public Health and Research: Aggregated coded data is used by health organizations and researchers to:

  • Track the prevalence and incidence of cryptorchidism.

  • Identify potential geographic or temporal clusters that might point to environmental causes.

  • Study the long-term outcomes of different treatment approaches.

  • Allocate public health resources effectively.

Coding Scenarios: Applying Q53 Correctly

• Scenario 1: A 1-year-old boy is seen for a pre-operative evaluation for a left undescended testis, palpable in the inguinal canal.

  • Correct Code: Q53.11 (Undescended testicle, unilateral, left).

• Scenario 2: A newborn is diagnosed with bilateral non-palpable testes.

  • Correct Code: Q53.20 (Undescended testicle, bilateral).

• Scenario 3: A 7-year-old boy is found to have a testis located in the perineum.

  • Correct Code: Q53.0 (Ectopic testis).

• Scenario 4: A 5-year-old boy is referred for an “undescended testis.” The urologist’s note states: “On examination, the right testis is retractile and can be manipulated easily into the mid-scrotum without tension. This is not a true cryptorchidism.”

  • Correct Code: N44.02 (Retractile testis). Q53.11 is incorrect.

The Link Between Coding and Public Health Data

If coders consistently use the nonspecific Q53.9 instead of the specific Q53.1 or Q53.2, the national data on the laterality of cryptorchidism becomes unreliable. This imprecision can hinder research efforts to understand if unilateral and bilateral cases have different etiologies or outcomes.

Documentation Requirements for Coders

The coder is entirely dependent on the clinician’s documentation. Clear and specific physician notes are paramount. The medical record should explicitly state:

• The diagnosis (e.g., “cryptorchidism”).

• Laterality (left, right, or bilateral).

• The type, if known (e.g., “canalicular,” “ectopic”).

• Whether it is palpable or non-palpable.

11. A Global Perspective: Cryptorchidism in Public Health

Cryptorchidism is a global health issue. While the basic principles of diagnosis and treatment are universal, access to care varies widely. In high-income countries, nearly all cases are identified and treated in a timely manner. In low-resource settings, diagnosis may be delayed, and surgical expertise may be limited, leading to a higher burden of long-term complications like infertility and advanced testicular cancer. International surgical mission trips often include orchidopexy as a core procedure, highlighting its importance in global pediatric surgical care.

12. Conclusion: Synthesizing Knowledge for Optimal Care

The ICD-10-CM code Q53 encapsulates a common yet complex congenital condition with lifelong implications. Timely diagnosis, before one year of age, is critical for optimal outcomes. Surgical orchidopexy remains the definitive treatment, aiming to preserve fertility and enable cancer surveillance. Accurate medical coding for cryptorchidism is essential, bridging clinical care with epidemiological research and healthcare economics to improve patient outcomes on a global scale.

13. Frequently Asked Questions (FAQs)

1. My newborn son has an undescended testicle. Should I be worried?
It is a common condition, and no immediate worry is necessary. Many testes descend on their own in the first few months. The key is to follow up regularly with your pediatrician. If it hasn’t descended by 6 months, a referral to a pediatric urologist is standard to plan for treatment, which is highly effective.

2. Does having surgery for an undescended testicle mean my son won’t get testicular cancer?
No, unfortunately, the surgery does not eliminate the underlying increased risk of testicular cancer. However, it is absolutely crucial because it places the testis in the scrotum where it can be monitored through self-examination and clinical check-ups. This allows for early detection, which is the key to a cure.

3. What is the difference between an undescended testicle and a retractile testicle?
A retractile testicle is a normal testicle that is just very mobile and gets pulled up into the groin by a strong muscle reflex but can be easily guided back into the scrotum. A true undescended testicle is stuck and cannot be manipulated into the scrotum. The retractile testicle does not require surgery and is not associated with the same risks.

4. Can cryptorchidism be prevented?
In most cases, the cause is unknown and not preventable. However, since certain maternal factors are associated with a higher risk, maintaining a healthy pregnancy—including avoiding smoking, alcohol, and managing conditions like diabetes—may help reduce the risk.

5. What happens if an undescended testicle is never treated?
The risks are significant and include a very high probability of infertility (especially if bilateral), a substantially increased risk of testicular cancer that would be difficult to detect, and a higher chance of complications like testicular torsion and associated hernia.

Date: October 23, 2025
Disclaimer: This article is intended for informational purposes only and does not constitute medical advice. The content is based on current medical knowledge and coding guidelines as of the publication date. Medical coding is complex and constantly evolving; always consult with a certified medical coder, clinical professional, and the most current official coding resources for definitive guidance.